TOVORAFENIB for Brain neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where TOVORAFENIB was used for Brain neoplasm.
Most Reported Side Effects for TOVORAFENIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Accidental underdose | 19 | 9.5% | 0 | 0 |
| Disease progression | 16 | 8.0% | 2 | 2 |
| Rash | 16 | 8.0% | 0 | 1 |
| Fatigue | 15 | 7.5% | 0 | 0 |
| Off label use | 13 | 6.5% | 2 | 3 |
| Headache | 12 | 6.0% | 0 | 3 |
| Hair colour changes | 11 | 5.5% | 0 | 1 |
| Blood creatine phosphokinase increased | 10 | 5.0% | 0 | 0 |
| Acne | 8 | 4.0% | 0 | 1 |
| Intracranial tumour haemorrhage | 8 | 4.0% | 0 | 2 |
| Dermatitis acneiform | 7 | 3.5% | 0 | 1 |
| Nausea | 7 | 3.5% | 0 | 1 |
| Blood phosphorus decreased | 6 | 3.0% | 0 | 1 |
| Growth retardation | 5 | 2.5% | 0 | 1 |
| Melanocytic naevus | 5 | 2.5% | 0 | 0 |
Other Indications for TOVORAFENIB
Product used for unknown indication (64)
Glioma (62)
Brain neoplasm malignant (37)
Astrocytoma (9)
Astrocytoma, low grade (7)
Other Drugs Used for Brain neoplasm
TEMOZOLOMIDE (286)
BEVACIZUMAB (166)
PROCARBAZINE (142)
ETOPOSIDE (121)
CARBOPLATIN (103)
VINCRISTINE (93)
CYCLOPHOSPHAMIDE (72)
CISPLATIN (67)
TRAMETINIB DIMETHYL SULFOXIDE (55)
BEVACIZUMAB-AWWB (50)